Since CDC42 plays a central role in establishing and maintaining epithelial polarity which is frequently disrupted during tumor progression, we first analyzed the subcellular localization of a series of polarity proteins in Kras or Kras/Cdc42 bronchioles at three weeks post Ad-Cre treatment. This evidence concerns the gene KRAS and neoplasm.